Website profile

Tradingview

Where the world charts, chats and trades markets. We're a supercharged super-charting platform and social network for traders and investors. Free to sign up.

  • 21,555articles · 30d
  • 1+ hour agolatest article
  • Aug 14, 2026earliest in window
  • 94%with images · 8 videos
  • 144avg words
articles per day
Categories
  • Economy, Business & Finance 20,407
  • Finance & Business 19,722
  • News 12,012
  • Finance 5,480
  • Business & Industrial 2,266
  • Industrial 600
  • Health & Wellness 353
  • Politics 259

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

TradingView
tradingview.com > news > urn:summary_document_transcript:quartr.com:4152152:0-vrtx-diversified-portfolio-advances-with-key-launches-and-milestones-in-renal-pain-and-endocrinology

VRTX: Diversified portfolio advances with key launches and milestones in renal, pain, and endocrinology

2+ day, 18+ hour ago   (83+ words) TradingView Recent acquisitions and pipeline progress have diversified the portfolio across five disease pillars, with key milestones ahead in renal, pain, and rare endocrine diseases. Commercial infrastructure has matured, supporting strong product launches and steady growth, especially in pain and…...

TradingView
tradingview.com > news > urn:summary_document_transcript:quartr.com:4144164:0-maze-promising-clinical-progress-in-kidney-and-metabolic-diseases-with-strong-financial-runway

MAZE: Promising clinical progress in kidney and metabolic diseases, with strong financial runway

4+ day, 4+ min ago   (79+ words) TradingView MAZE: Promising clinical progress in kidney and metabolic diseases, with strong financial runway Three clinical programs are advancing, with MZE829 showing promising phase II results in AMKD and MZE782 progressing in PKU and CKD. HORIZON study adjustments aim for balanced enrollment,…...

TradingView
tradingview.com > news > urn:summary_document_slides:quartr.com:4105300:0-bakka-strong-earnings-growth-and-robust-faroe-islands-results-offset-scotland-s-operational-challenges

BAKKA: Strong earnings growth and robust Faroe Islands results offset Scotland's operational challenges

1+ week, 6+ day ago   (69+ words) TradingView BAKKA: Strong earnings growth and robust Faroe Islands results offset Scotland's operational challenges Revenue and operational EBIT surged year-over-year, driven by strong Faroe Islands performance and improved cash flow. Scotland faced challenges with lower volumes and negative margins, while…...